{"blog": [], "keywords": [{"value": "Theranos Inc", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "Holmes, Elizabeth (1984- )", "name": "persons", "rank": "2", "is_major": "Y"}, {"value": "Tests (Medical)", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "Blood", "name": "subject", "rank": "4", "is_major": "Y"}, {"value": "Boies, David", "name": "persons", "rank": "5", "is_major": "N"}, {"value": "Centers for Medicare and Medicaid Services", "name": "organizations", "rank": "6", "is_major": "N"}, {"value": "Securities and Exchange Commission", "name": "organizations", "rank": "7", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/04/25/business/theranoss-fate-rests-with-afounder-who-answers-only-to-herself.html", "document_type": "article", "byline": {"person": [{"lastname": "ABELSON", "firstname": "Reed", "role": "reported", "organization": "", "rank": 1}], "original": "By REED ABELSON", "contributor": "Katie Benner contributed reporting."}, "type_of_material": "News", "multimedia": [{"url": "images/2016/04/25/business/25theranos-web/25theranos-web-thumbWide.jpg", "legacy": {"wide": "images/2016/04/25/business/25theranos-web/25theranos-web-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/04/25/business/25theranos-web/25theranos-web-articleLarge.jpg", "legacy": {"xlarge": "images/2016/04/25/business/25theranos-web/25theranos-web-articleLarge.jpg", "xlargeheight": "400", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 400}, {"url": "images/2016/04/25/business/25theranos-web/25theranos-web-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/04/25/business/25theranos-web/25theranos-web-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "1236", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Under criminal investigation and with skepticism about its core technology rising, a onetime Silicon Valley favorite\u2019s future is largely up to its founder, Elizabeth Holmes.", "pub_date": "2016-04-25T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Theranos\u2019s Fate Rests With a Founder Who Has to Answer Only to Herself", "main": "Theranos\u2019s Fate Rests With a Founder Who Answers Only to Herself"}, "print_page": "1", "snippet": "Under criminal investigation and with skepticism about its core technology rising, a onetime Silicon Valley favorite\u2019s future is largely up to its founder, Elizabeth Holmes.", "_id": "571d5e9538f0d8550bf1a660", "slideshow_credits": null, "abstract": "Board members and investors in Theranos await announcement of management changes from founder and chief executive Elizabeth Holmes amid criminal investigation and persistent questions about whether core blood-testing technology works; insiders acknowledge that they have little leverage to effect change, underscoring peril of investing in firms where founder like Holmes exerts complete control. "}